GBI Research

GBI Research provides industry-leading global business intelligence solutions. Our products and services help companies make better business decisions, win business and position themselves more effectively. GBI Research publishes more than 100 research reports per annum across a wide range of industries. Our reports draw on in-depth primary and secondary research, databases of proprietary in-house data and high quality analysis from our expert teams. GBI Research employs hundreds of highly qualified Analysts across the US, Europe and Asia. Key report types currently published by GBI Research i
nclude:

  • Market Intelligence Reports: premium analytical reports based on a combination of market data, company, deals and project content, industry surveys and additional primary and secondary research.
  • Benchmarking Reports: analytical reports comparing key financial indicators for the top 20 companies in a particular industry and geography.
  • Industry Outlook Reports: survey-based reports, revealing and analyzing the leading experts' opinions on the future of the industry covered.
  • Market Profiles: overview-level reports based on market, company and demographic data.
  • Pipeline Analysis Reports: reports analyzing the unmet need, market size and product pipeline for different disease indications, based on a detailed database of developmental products.
GBI Research
 

List of reports from GBI Research

< prev 1    3  4  5  6  7  8  9  10  
Colorectal Cancer Therapeutics in Major Developed Markets to 2020 - Increased Uptake of High Priced Drugs to Offset the Impact of Generics
1/31/2015 | published by: GBI Research
... research, “Colorectal Cancer Therapeutics in Major Developed Markets to 2020 - Increased Uptake of High Priced Drugs to Offset the Impact of Generics”, which provides in-depth analysis of the Colorectal Cancer (CRC) therapeutics market in ...  |  read more...
USD 4,995
Frontier Pharma: Pain - Identifying and Commercializing First-in-Class Innovation
1/31/2015 | published by: GBI Research
... of molecular targets. GBI Research’s analyses identified 122 first-in-class programs in active development, constituting 13.6% of the pipeline and acting on 65 first-in-class molecular targets, indicating a high degree of innovation. This is in stark ...  |  read more...
USD 6,995
Frontier Pharma: Antibiotics - Identifying and Commercializing First-in-Class Innovation
12/31/2014 | published by: GBI Research
... majority (85%) are at the Discovery or Preclinical stages and have not yet entered human trials. Such a high proportion of drugs at the earliest stages of development would, in other indications, provide hope of ...  |  read more...
USD 6,995
Rheumatoid Arthritis Market to 2020 - A Crowded Market Characterized by Modest Growth
12/31/2014 | published by: GBI Research
... progressive and currently incurable autoimmune disease that primarily affects joints. It is characterized by synovial inflammation and gradual bone erosion over many years, and disease progression results in stiffness and pain, especially in the hands ...  |  read more...
USD 4,995
Frontier Pharma: Liver Cancer - Identifying and Commercializing First-in-Class Innovation
12/31/2014 | published by: GBI Research
... the pipeline devoted to innovative products is considerably larger than both the industry and oncology average, which is a promising sign for novel therapeutics reaching the liver cancer market. The contrast between the market and ...  |  read more...
USD 6,995
Market Digest: Multiparameter Patient Monitoring Devices 2006 to 2020 - Europe (Germany, France, Italy, UK and Spain)
12/20/2014 | published by: GBI Research
... Italy, UK and Spain)” provides quantitative analysis of the four multiparameter patient monitoring devices market segments: high acuity monitors, mid acuity monitors, low acuity monitors and multiparameter central stations. The analysis includes market size data ...  |  read more...
USD 1,750
Frontier Pharma: Parkinson’s Disease - Identifying and Commercializing First-in-Class Innovation
11/30/2014 | published by: GBI Research
... but a stark contrast between the mechanisms of action employed in the current market and the pipeline is evident. Where the market relies on symptomatic treatments that target neuromodulatory receptors, the pipeline shows a diverse ...  |  read more...
USD 6,995
Frontier Pharma: Alzheimer’s Disease - Identifying and Commercializing First-in-Class Innovation
11/30/2014 | published by: GBI Research
... GBI Research analysis revealed a high degree of innovation in this indication, with 46% of the pipeline being first-in-class products, acting on over 40 first-in-class molecular targets. In addition, the pipeline is characterized by the ...  |  read more...
USD 6,995
Type 2 Diabetes Therapeutics in Asia-Pacific Markets to 2020 - Increasing Uptake of Novel Drug Classes to Drive Market Growth
11/30/2014 | published by: GBI Research
... 2 Diabetes Therapeutics in Asia-Pacific Markets to 2020 - Increasing Uptake of Novel Drug Classes to Drive Market Growth”, which provides insights into type 2 diabetes in the Asia-Pacific (APAC) markets of China, India, Japan ...  |  read more...
USD 4,995
Frontier Pharma: Prostate Cancer - Identifying and Commercializing First-in-Class Innovation
11/30/2014 | published by: GBI Research
... across all stages. The range of mechanisms of action employed by these compounds is also highly diverse, especially in comparison to the existing market landscape. More pertinently, the degree and proportion of breakthrough innovations in ...  |  read more...
USD 6,995
Market Digest: Aesthetic Lasers and Energy Devices Market 2006 to 2020 - Asia-Pacific
11/18/2014 | published by: GBI Research
... the three aesthetic lasers and energy devices market segments: minimally invasive body contouring devices, non-invasive body contouring devices and laser resurfacing devices. The analysis includes market size data by revenue and volume over the 2006–2020 ...  |  read more...
USD 1,750
Picture Archiving and Communication Systems Market to 2020 - Digitization of Healthcare Systems and Evolution of PACS as a Decision Support Tool Drive Growth
10/31/2014 | published by: GBI Research
... to 2020 - Digitization of Healthcare Systems and Evolution of PACS as a Decision Support Tool Drive Growth” discusses the market, competitive landscape, and trends for two Picture Archiving and Communications Systems (PACS) market segments: ...  |  read more...
USD 3,500
Frontier Pharma: Non-Small Cell Lung Cancer - Identifying and Commercializing First-in-Class Innovation
10/31/2014 | published by: GBI Research
... contrast between the mechanisms of action employed in the current market and the pipeline is evident. Where the market comprises primarily ineffective chemotherapies that target tubulin or DNA replication, the pipeline shows an incredibly diverse ...  |  read more...
USD 6,995
Major Depressive Disorder Therapeutics in Major Developed Markets to 2020 - New Launches and Modest Uptake of New Adjunctive Treatments to Offset Patent Expiries
10/31/2014 | published by: GBI Research
... its latest research, Major Depressive Disorder Therapeutics in Major Developed Markets to 2020 - New Launches and Modest Uptake of New Adjunctive Treatments to Offset Patent Expiries, which provides insights into Major Depressive Disorder (MDD) ...  |  read more...
USD 4,995
Non-Hodgkin Lymphoma Therapeutics in Major Developed Markets to 2020 - New Entrants and Promising Pipeline Widen Targeted and Immunotherapeutic Treatment Options
10/31/2014 | published by: GBI Research
... report, “Non-Hodgkin Lymphoma Therapeutics in Major Developed Markets to 2020 - New Entrants and Promising Pipeline Widen Targeted and Immunotherapeutic Treatment Options”, which provides in-depth insight into the indication. It provides estimates of market size ...  |  read more...
USD 4,995
Colorectal Cancer Therapeutics in Asia-Pacific Markets to 2020 - Improved Regional Healthcare Access to Drive Uptake of High-Cost Targeted Therapies
10/31/2014 | published by: GBI Research
... Cancer Therapeutics in Asia-Pacific Markets to 2020 - Improved Regional Healthcare Access to Drive Uptake of High-Cost Targeted Therapies"", which provides in-depth insights into the indication. It gives an estimation of market size for 2013 ...  |  read more...
USD 4,995
Market Digest: Cardiac Rhythm Management Devices 2006 to 2020 - US and Europe (US, Germany, France, Italy, UK, Spain)
10/20/2014 | published by: GBI Research
... Defibrillators 3.2.2 Cardiac Resynchronization Therapy - Pacemakers 3.3 Implantable Cardioverter Defibrillators 3.3.1 Dual Chamber Implantable Cardioverter Defibrillators 3.3.2 Single Chamber Implantable Cardioverter Defibrillators 3.4 Implantable Loop Recorders 3.5 Pacemakers 3.5.1 Dual Chamber Pacemakers 3.5.2 Single ...  |  read more...
USD 1,750
Market Digest: Aesthetic Lasers and Energy Devices Market 2006 to 2020 - Europe (Germany, France, Italy, UK, Spain)
10/1/2014 | published by: GBI Research
... devices market revenue and volume for the following segments: Minimally Invasive Body Contouring (MIBC) Devices, Non-Invasive Body Contouring (NIBC) Devices and Laser Resurfacing (LR) Devices. The report also provides company shares by revenue for the ...  |  read more...
USD 1,750
Acute Myeloid Leukemia Therapeutics Market to 2020 - Novel Therapies to Offer Clinical Benefit in Small Patient Cohorts
9/30/2014 | published by: GBI Research
... - Novel Therapies to Offer Clinical Benefit in Small Patient Cohorts Treatment and prognosis in AML is strongly influenced by a patient’s age, and their cytogenetic profile. In the majority of cases these two prognostic ...  |  read more...
USD 4,995
Melanoma Therapeutics Market to 2020 - Rising Prevalence and Evolving Treatment Algorithms to Drive Market Growth
9/30/2014 | published by: GBI Research
... 2020 - Rising Prevalence and Evolving Treatment Algorithms to Drive Market Growth” Melanoma is a highly heterogeneous disease comprising Cutaneous Melanoma (CM), Ocular Melanoma (OM), Mucosal Melanoma (MM), melanoma of the internal organs, and, according ...  |  read more...
USD 4,995
Non-Hodgkin Lymphoma Therapeutics in Asia-Pacific Markets to 2020 - Novel Technologies Show Considerable Promise in Relapsed/Refractory Setting
9/15/2014 | published by: GBI Research
... Asia-Pacific Markets to 2020 - Novel Technologies Show Considerable Promise in Relapsed/Refractory Setting’, which provides in-depth insights into the indication. It gives an estimation of market size for 2013 along with forecasts until 2020 for ...  |  read more...
USD 4,995
Market Digest: Mammography Systems 2006 to 2020 - Americas (US, Canada, Brazil, Mexico)
9/1/2014 | published by: GBI Research
... the two mammography systems market segments: full field mammography systems and film-screen mammography systems. The analysis includes market size data by revenue and volume over the 2006–2020 period for the following countries: the US, Canada, ...  |  read more...
USD 1,750
Ventilators Market to 2020 - Technical Advances and Hospital Expansion Serve as Distinct Regional Growth Drivers
8/31/2014 | published by: GBI Research
... Growth Drivers” discusses the market, competitive landscape, and trends for three ventilator market segments: Adult/pediatric, neonatal and transport ventilators.It provides comprehensive information on the key trends affecting these segments, and key analytical content on the ...  |  read more...
USD 3,500
Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM
8/20/2014 | published by: GBI Research
... research, Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM, which provides in-depth analysis of the Glioblastoma Multiforme (GBM) therapeutics market within ...  |  read more...
USD 4,995
Market Digest: Transcatheter Heart Valve 2007 to 2020 - Europe (Germany, France, Italy, UK, Spain)
8/12/2014 | published by: GBI Research
... provides quantitative analysis of the transcatheter heart valves market in Europe. The analysis includes market size data by revenue and volume over the 2007–2020 period and key company share data by revenue in 2013 for ...  |  read more...
USD 1,750
< prev 1    3  4  5  6  7  8  9  10  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!